AEMD: Advancing The Hemopurifier in Two Feasibility Studies

AEMD: Advancing The Hemopurifier in Two Feasibility StudiesBy M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical Inc. (NASDAQ:AEMD) is a medical technology company engaged in developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threatening and are not addressed with already approved treatments. The company’s lead product, the Hemopurifier®, is a blood filtration device that is



Yahoo Finance

You may also like...